On 2025-05-12, Bolt Biotherapeutics, Inc. (BOLT) announced earnings per share of $-5.80 for the fiscal quarter ending 2025-03-31, beating the average analyst estimate of $-6.80.
The next expected annoucement date for quarterly earnings is 2025-08-12, with an average estimated earnings per share of $-6.40 for the fiscal quarter ending 2025-06-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2025-05-12 | 2025-03-31 | $-6.80 | $-5.80 |
| 2025-03-24 | 2024-12-31 | $-7.60 | $-7.60 |
| 2024-11-12 | 2024-09-30 | $-7.20 | $-8.00 |
| 2024-08-13 | 2024-06-30 | $-10.80 | $-11.20 |
| 2024-05-14 | 2024-03-31 | $-10.20 | $-5.60 |
| 2024-03-21 | 2023-12-31 | $-9.40 | $-9.40 |
| 2023-11-09 | 2023-09-30 | $-9.80 | $-8.60 |
| 2023-08-07 | 2023-06-30 | $-10.60 | $-9.60 |
| 2023-05-11 | 2023-03-31 | $-9.80 | $-9.00 |
| 2023-03-29 | 2022-12-31 | $-12.60 | $-10.60 |
| 2022-11-10 | 2022-09-30 | $-11.20 | $-11.60 |
| 2022-08-10 | 2022-06-30 | $-13.60 | $-12.20 |
| 2022-05-12 | 2022-03-31 | $-14.20 | $-12.80 |
| 2022-03-30 | 2021-12-31 | $-13.20 | $-14.60 |
| 2021-11-09 | 2021-09-30 | $-12.60 | $-12.60 |
| 2021-08-12 | 2021-06-30 | $-7.60 | $-12.80 |
| 2021-05-13 | 2021-03-31 | $-12.80 | $-17.20 |
| 2021-03-31 | 2020-12-31 | $-14.40 | $-159.00 |